» Articles » PMID: 32802550

Simultaneous Determination of 34 Amino Acids in Tumor Tissues from Colorectal Cancer Patients Based on the Targeted UHPLC-MS/MS Method

Overview
Publisher Wiley
Specialty Chemistry
Date 2020 Aug 18
PMID 32802550
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A targeted ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was established and validated for the simultaneous determination of 34 amino acids in tissue samples from colorectal cancer (CRC) patients. The chromatographic separation was achieved on an Agilent ZORBAX SB-C column (3.0 × 150 mm, 5 m) with a binary gradient elution system (A, 0.02% heptafluorobutyric acid and 0.2% formic acid in water, v/v; B, methanol). The run time was 10 min. The multiple reaction monitoring mode was chosen with an electrospray ionization source operating in the positive ionization mode for data acquisition. The linear correlation coefficients were >0.99 for all the analytes in their corresponding calibration ranges. The sample was pretreated based on tissue homogenate and protein precipitation with a 100 mg aliquot sample. The average recovery and matrix effect for 34 amino acids and 3 internal standards were 39.00%∼146.95% and 49.45%∼173.63%, respectively. The intra- and interday accuracy for all the analytes ranged from -13.52% to 14.21% (RSD ≤8.57%) and from -14.52% to 12.59% (RSD ≤10.31%), respectively. Deviations of stability under different conditions were within ±15% for all the analytes. This method was applied to simultaneous quantification of 34 amino acids in tissue samples from 94 CRC patients.

Citing Articles

Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients.

Santos M, Barros I, Brandao P, Lacerda L Cancers (Basel). 2024; 16(1).

PMID: 38201497 PMC: 10778074. DOI: 10.3390/cancers16010069.


Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics.

Yang Y, Wang Z, Li X, Lv J, Zhong R, Gao S J Transl Med. 2023; 21(1):824.

PMID: 37978537 PMC: 10655464. DOI: 10.1186/s12967-023-04604-7.

References
1.
Jimenez B, Mirnezami R, Kinross J, Cloarec O, Keun H, Holmes E . 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication. J Proteome Res. 2012; 12(2):959-68. DOI: 10.1021/pr3010106. View

2.
Manig F, Kuhne K, von Neubeck C, Schwarzenbolz U, Yu Z, Kessler B . The why and how of amino acid analytics in cancer diagnostics and therapy. J Biotechnol. 2016; 242:30-54. DOI: 10.1016/j.jbiotec.2016.12.001. View

3.
Siminska E, Koba M . Amino acid profiling as a method of discovering biomarkers for early diagnosis of cancer. Amino Acids. 2016; 48(6):1339-45. DOI: 10.1007/s00726-016-2215-2. View

4.
Kleinrok Z, Matuszek M, Jesipowicz J, Matuszek B, Opolski A, RADZIKOWSKI C . GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol Pharmacol. 1998; 49(2):303-10. View

5.
Farshidfar F, Weljie A, Kopciuk K, Buie W, MacLean A, Dixon E . Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med. 2012; 4(5):42. PMC: 3506908. DOI: 10.1186/gm341. View